Targeted Degradation of Proteins Localized in Subcellular Compartments by Hybrid Small Molecules-Reference-Cited by-同舟云学术

Targeted Degradation of Proteins Localized in Subcellular Compartments by Hybrid Small Molecules

Published:2016-12-13 Issue:3 Volume:91 Page:159-166
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Okuhira Keiichiro,Shoda Takuji,Omura Risa,Ohoka Nobumichi,Hattori Takayuki,Shibata Norihito,Demizu Yosuke,Sugihara Ryo,Ichino Asato,Kawahara Haruka,Itoh Yukihiro,Ishikawa Minoru,Hashimoto Yuichi,Kurihara Masaaki,Itoh Susumu,Saito Hiroyuki,Naito Mikihiko

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference28 articles.

1. Catalytic in vivo protein knockdown by small-molecule PROTACs

2. A Pharmacologic Inhibitor of the Protease Taspase1 Effectively Inhibits Breast and Brain Tumor Growth

3. Physical and Functional Interactions between Cellular Retinoic Acid Binding Protein II and the Retinoic Acid-Dependent Nuclear Complex

4. Design and synthesis of estrogen receptor degradation inducer based on a protein knockdown strategy;Demizu;Bioorg Med Chem Lett,2012

5. Integrating Clinical Pharmacology Concepts in Individualized Therapy With Tyrosine Kinase Inhibitors

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harmony of Protein Tags and Chimeric Molecules Empowers Targeted Protein Ubiquitination and Beyond;Cells;2024-02-28

2. Recent advancements in targeted protein knockdown technologies—emerging paradigms for targeted therapy;Exploration of Targeted Anti-tumor Therapy;2023-12-26

3. PROTACs: A novel strategy for cancer drug discovery and development;MedComm;2023-05-29

4. Conjugation of the Fn14 Ligand to a SMAC Mimetic Selectively Suppresses Experimental Squamous Cell Carcinoma in Mice;Journal of Investigative Dermatology;2023-02

5. Targeting androgen receptor degradation with PROTACs from bench to bedside;Biomedicine & Pharmacotherapy;2023-02